Clinical trial

Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144

NCT01435135

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention ALVAC-HIV Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention AIDSVAX B/E Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention ALVAC-HIV Placebo Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention AIDSVAX B/E Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE2

Conditions

HIV Infectionsunresolved

Interventions

ALVAC-HIVBIOLOGICAL

AIDSVAX B/EBIOLOGICAL

ALVAC-HIV PlaceboBIOLOGICAL

AIDSVAX B/E PlaceboBIOLOGICAL

Sponsors & collaborators

U.S. Army Medical Research and Development Commandlead sponsor

National Institutes of Health (NIH)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01435135 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.